143 related articles for article (PubMed ID: 37306355)
1. Uterine sarcoma - time is worth its weight in gold.
Pruski D; Millert-Kalińska S; Mądry R; Kotynia K; Pawełek T; Rusek D; Zmaczyński A; Jach R; Przybylski M
Pol J Pathol; 2023; 74(1):59-62. PubMed ID: 37306355
[TBL] [Abstract][Full Text] [Related]
2. Soft Tissue and Uterine Leiomyosarcoma.
George S; Serrano C; Hensley ML; Ray-Coquard I
J Clin Oncol; 2018 Jan; 36(2):144-150. PubMed ID: 29220301
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
Wang F; Dai X; Chen H; Hu X; Wang Y
BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
[TBL] [Abstract][Full Text] [Related]
4. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
5. Overview of malignant soft-tissue sarcomas of the limbs.
Renn A; Adejolu M; Messiou C; Bhaludin B; Strauss DC; Thway K; Moskovic E
Clin Radiol; 2021 Dec; 76(12):940.e1-940.e16. PubMed ID: 34607656
[TBL] [Abstract][Full Text] [Related]
6. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and surgical therapy of uterine sarcoma.
Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
[TBL] [Abstract][Full Text] [Related]
8. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
[TBL] [Abstract][Full Text] [Related]
9. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapeutics in the Treatment of Uterine Sarcoma.
Bose S; Schwartz GK; Ingham M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():900-909. PubMed ID: 35714303
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I; Gracia Segovia M; Macuks R; Mancari R; Achimas-Cadariu P; Corrado G; Bartusevicius A; Sukhin V; Muruzabal JC; Coronado Martín PJ; Gardella B; Piek JM; Concin N; Arab C; Papatheodorou D; Polterauer S; Iacoponi S; Nieto T; Lopez-Sanclemente MC; Trukhan H; Gil MM; Bakinovskaya I; Dalamanava A; Cucurull M; Rovski D; Baquedano L; Chiva L; Mardas M; Mavrichev SA; Klat J; Lopez de la Manzanara CA; Yildirim Y;
Int J Gynecol Cancer; 2023 Jun; 33(6):897-904. PubMed ID: 37192761
[TBL] [Abstract][Full Text] [Related]
12. Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas.
Hensley ML
Curr Opin Oncol; 2010 Jul; 22(4):356-61. PubMed ID: 20520541
[TBL] [Abstract][Full Text] [Related]
13. Leiomyosarcoma of the urinary bladder: A SEER database study and comparison to leiomyosarcomas of the uterus and extremities/trunk.
Coiner BL; Cates J; Kamanda S; Giannico GA; Gordetsky JB
Ann Diagn Pathol; 2021 Aug; 53():151743. PubMed ID: 33964611
[TBL] [Abstract][Full Text] [Related]
14. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures.
Ravid Y; Formanski M; Smith Y; Reich R; Davidson B
Gynecol Oncol; 2016 Mar; 140(3):512-7. PubMed ID: 26768834
[TBL] [Abstract][Full Text] [Related]
15. Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcoma.
Gyorki DE; Choong PFM; Slavin J; Henderson MA
ANZ J Surg; 2018 Apr; 88(4):274-277. PubMed ID: 28768365
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of uterine sarcomas.
Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
[TBL] [Abstract][Full Text] [Related]
17. Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.
Sparić R; Andjić M; Babović I; Nejković L; Mitrović M; Štulić J; Pupovac M; Tinelli A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077127
[TBL] [Abstract][Full Text] [Related]
18. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
Tanriverdi O; Yildiz A
J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
[TBL] [Abstract][Full Text] [Related]
19. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
20. CLINICAL MANAGEMENT OF SOFT PART SARCOMAS.
BOWDEN L
Ann N Y Acad Sci; 1964 Apr; 114():1047-60. PubMed ID: 14131913
[No Abstract] [Full Text] [Related]
[Next] [New Search]